Live feed
Filing
SC 13D
SC 13D0000950142-23-002836·Keenova Therapeutics plc
Schedule 13D ownership disclosure
Mallinckrodt plc
Security class unavailable
Event date: 2023-11-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950142-23-002836
- Form type
- SC 13D
- Filer
- Keenova Therapeutics plc
- CIK
- CIK 1567892
- Filed
- Nov 24, 2023
- Reporting period
- Nov 14, 2023
- Description
- Schedule 13D beneficial ownership